Andrew Huntley is a Senior Managing Director of BDA. Having joined the co-founders in 1998, he established and oversaw BDA’s early Asian offices including Singapore, Shanghai and Hong Kong, subsequently co-managed BDA’s New York office from 2002 to 2005, and managed its London office from 2005 to 2018.

He now travels widely in Asia and Europe from his base in Ho Chi Minh City and oversees BDA’s global Healthcare & Life Sciences sector.  Mr. Huntley has advised clients on transactions across Asia as well as in Europe and North America, including both blue chip corporate clients such as Arkema, Celestica, Clariant, Edenred, Henkel, Jardine Matheson, Johnson Matthey, Laird Group, Rexel, Sumitomo Chemical, SunGard, ThomsonReuters, Tata Motors and Weir Group as well as financial sponsors such as Actis, Ardian, Bregal Capital, EQT, LDC, Investcorp, Mekong Capital, Nova Capital, Prudential, Segulah, Seera and STIC. Before BDA, Mr. Huntley worked for the Jardine Matheson Group in HK, China, Taiwan and Vietnam. He acted as the Group Representative in Vietnam and had executive responsibility for Group businesses there and in Taiwan. Mr. Huntley was educated at Oxford University (MA Hons, Chinese). He is fluent in Mandarin and conversant in Vietnamese.